| - GRCh37:
- Chr5:156191373
- GRCh38:
- Chr5:156764362
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156191336
- GRCh38:
- Chr5:156764325
| SGCD | | Dilated cardiomyopathy 1L, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156191187
- GRCh38:
- Chr5:156764176
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156191097
- GRCh38:
- Chr5:156764086
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156189345
- GRCh38:
- Chr5:156762334
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156189215
- GRCh38:
- Chr5:156762204
| SGCD | | Dilated cardiomyopathy 1L, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156189198
- GRCh38:
- Chr5:156762187
| SGCD | | Dilated cardiomyopathy 1L, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156189121
- GRCh38:
- Chr5:156762110
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156187759
- GRCh38:
- Chr5:156760748
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156187684
- GRCh38:
- Chr5:156760673
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156187448
- GRCh38:
- Chr5:156760437
| SGCD | | Dilated cardiomyopathy 1L, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156187438
- GRCh38:
- Chr5:156760427
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156187345
- GRCh38:
- Chr5:156760334
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156184677
- GRCh38:
- Chr5:156757666
| SGCD | C220S, C221S | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:155935627
- GRCh38:
- Chr5:156508617
| SGCD | L69P, L70P | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193967
- GRCh38:
- Chr5:156766956
| SGCD | | Dilated cardiomyopathy 1L, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156192905
- GRCh38:
- Chr5:156765894
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156192662
- GRCh38:
- Chr5:156765651
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156192587
- GRCh38:
- Chr5:156765576
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156192534
- GRCh38:
- Chr5:156765523
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156192528
- GRCh38:
- Chr5:156765517
| SGCD | | Dilated cardiomyopathy 1L, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156188922
- GRCh38:
- Chr5:156761911
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156188877
- GRCh38:
- Chr5:156761866
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156187283
- GRCh38:
- Chr5:156760272
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156187218
- GRCh38:
- Chr5:156760207
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Apr 20, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156186962
- GRCh38:
- Chr5:156759951
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156192465
- GRCh38:
- Chr5:156765454
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156192285
- GRCh38:
- Chr5:156765274
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156190852
- GRCh38:
- Chr5:156763841
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194757
- GRCh38:
- Chr5:156767746
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156194752
- GRCh38:
- Chr5:156767741
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193423
- GRCh38:
- Chr5:156766412
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193386
- GRCh38:
- Chr5:156766375
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193276
- GRCh38:
- Chr5:156766265
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156192220
- GRCh38:
- Chr5:156765209
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156192140
- GRCh38:
- Chr5:156765129
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156191816
- GRCh38:
- Chr5:156764805
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156188567
- GRCh38:
- Chr5:156761556
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156188553
- GRCh38:
- Chr5:156761542
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156188540
- GRCh38:
- Chr5:156761529
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156188490
- GRCh38:
- Chr5:156761479
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156188405
- GRCh38:
- Chr5:156761394
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 15, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156188391
- GRCh38:
- Chr5:156761380
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156188308
- GRCh38:
- Chr5:156761297
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156188307
- GRCh38:
- Chr5:156761296
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156186936
- GRCh38:
- Chr5:156759925
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156186841
- GRCh38:
- Chr5:156759830
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156186574
- GRCh38:
- Chr5:156759563
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Mar 23, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:155753951
- GRCh38:
- Chr5:156326941
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193065
- GRCh38:
- Chr5:156766054
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156193037
- GRCh38:
- Chr5:156766026
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156192948
- GRCh38:
- Chr5:156765937
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156192919
- GRCh38:
- Chr5:156765908
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156191598
- GRCh38:
- Chr5:156764587
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156189981
- GRCh38:
- Chr5:156762970
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156188289
- GRCh38:
- Chr5:156761278
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156188278
- GRCh38:
- Chr5:156761267
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156188189
- GRCh38:
- Chr5:156761178
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156187979
- GRCh38:
- Chr5:156760968
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156184730
- GRCh38:
- Chr5:156757719
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194747
- GRCh38:
- Chr5:156767736
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194640
- GRCh38:
- Chr5:156767629
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194640
- GRCh38:
- Chr5:156767629
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194513
- GRCh38:
- Chr5:156767502
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194472
- GRCh38:
- Chr5:156767461
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194442
- GRCh38:
- Chr5:156767431
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194278
- GRCh38:
- Chr5:156767267
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:155756603
- GRCh38:
- Chr5:156329593
| SGCD | | Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, not specified
| Conflicting interpretations of pathogenicity (Oct 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:156186360
- GRCh38:
- Chr5:156759349
| SGCD | A278T, A277T | Qualitative or quantitative defects of delta-sarcoglycan, not provided, Autosomal recessive limb-girdle muscular dystrophy type 2F
| Conflicting interpretations of pathogenicity (Oct 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:156186245
- GRCh38:
- Chr5:156759234
| SGCD | | not specified, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F, Inborn genetic diseases, not provided | Conflicting interpretations of pathogenicity (Oct 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:156194781
- GRCh38:
- Chr5:156767770
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan
| Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156194756
- GRCh38:
- Chr5:156767745
| SGCD | | Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194511
- GRCh38:
- Chr5:156767500
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive
| Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156194495-156194496
- GRCh38:
- Chr5:156767484-156767485
| SGCD | | Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan, Dilated Cardiomyopathy, Dominant
| Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194495-156194496
- GRCh38:
- Chr5:156767484-156767485
| SGCD | | Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan, Dilated Cardiomyopathy, Dominant
| Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194272
- GRCh38:
- Chr5:156767261
| SGCD | | Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194267
- GRCh38:
- Chr5:156767256
| SGCD | | Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan | Benign/Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194217
- GRCh38:
- Chr5:156767206
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan, Limb-Girdle Muscular Dystrophy, Recessive | Benign/Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194216
- GRCh38:
- Chr5:156767205
| SGCD | | Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156194215
- GRCh38:
- Chr5:156767204
| SGCD | | Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan | Benign/Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193997
- GRCh38:
- Chr5:156766986
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, not provided, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive | Benign/Likely benign (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156193960
- GRCh38:
- Chr5:156766949
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive
| Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156193922
- GRCh38:
- Chr5:156766911
| SGCD | | Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan | Conflicting interpretations of pathogenicity (Jan 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:156193908
- GRCh38:
- Chr5:156766897
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan
| Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156193907
- GRCh38:
- Chr5:156766896
| SGCD | | Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193890
- GRCh38:
- Chr5:156766879
| SGCD | | Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193701
- GRCh38:
- Chr5:156766690
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan, not provided, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive | Benign/Likely benign (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156193699
- GRCh38:
- Chr5:156766688
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive
| Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156193632
- GRCh38:
- Chr5:156766621
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive
| Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156193620
- GRCh38:
- Chr5:156766609
| SGCD | | Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193597
- GRCh38:
- Chr5:156766586
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan, Limb-Girdle Muscular Dystrophy, Recessive | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193318
- GRCh38:
- Chr5:156766307
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan, Limb-Girdle Muscular Dystrophy, Recessive | Conflicting interpretations of pathogenicity (Jan 13, 2018) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr5:156193234
- GRCh38:
- Chr5:156766223
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan
| Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156193186
- GRCh38:
- Chr5:156766175
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan, Limb-Girdle Muscular Dystrophy, Recessive | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193118
- GRCh38:
- Chr5:156766107
| SGCD | | not provided, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive, Qualitative or quantitative defects of delta-sarcoglycan | Benign (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:156193084
- GRCh38:
- Chr5:156766073
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan, Limb-Girdle Muscular Dystrophy, Recessive | Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193066
- GRCh38:
- Chr5:156766055
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan, Limb-Girdle Muscular Dystrophy, Recessive | Benign/Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193062
- GRCh38:
- Chr5:156766051
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan, Dilated Cardiomyopathy, Dominant, Limb-Girdle Muscular Dystrophy, Recessive
| Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193046
- GRCh38:
- Chr5:156766035
| SGCD | | Qualitative or quantitative defects of delta-sarcoglycan, Dilated Cardiomyopathy, Dominant, Limb-Girdle Muscular Dystrophy, Recessive
| Uncertain significance (Jun 14, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr5:156193045-156193046
- GRCh38:
- Chr5:156766034-156766035
| SGCD | | Dilated cardiomyopathy 1L, Autosomal recessive limb-girdle muscular dystrophy type 2F, Qualitative or quantitative defects of delta-sarcoglycan, Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated Cardiomyopathy, Dominant, Dilated cardiomyopathy 1L, Limb-Girdle Muscular Dystrophy, Recessive | Uncertain significance (Feb 8, 2023) | criteria provided, multiple submitters, no conflicts |